/Companies

Satori Pharmaceuticals

Cambridge, US · 2 known investors

Find your way into Satori Pharmaceuticals

Sign up to see every warm intro you have to Satori Pharmaceuticals

  • Paths you didn't know you had: your email and LinkedIn already hold routes to the Satori Pharmaceuticals team. We find them for you
  • 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
  • Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone

Days of research, done the moment you sign in, with every route ranked by how warm it is.

Founders & leadership

JI
Jeffrey IvesExecutive

Board

DS
David SchnellBoard director
CE
Chris EhrlichBoard director
EM
Edward MathersBoard director
SM
Stephen MunizBoard director
BS
Bennett ShapiroBoard director

Investors · 2

Reported raises · per SEC filings

Form D private placements

$15M disclosed across 1 round · 2012

▶$15MraisedFeb 2012 · Pharmaceuticals
Rule 506(b)
Officers, directors & promoters on the filing
  • Bennett ShapiroDirector
  • Jeffrey IvesExecutive Officer, Director
  • David SchnellDirector
  • Chris EhrlichDirector
  • Edward MathersDirector
  • Stephen MunizDirector
Offering amount
$19.2M
Amount sold
$15M
First sale
Feb 2012
Incorporated
Corporation, Delaware
Federal exemptions
06
Full filing on SEC EDGAR ↗

Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.

Frequently asked questions

Who are Satori Pharmaceuticals's investors?
Satori Pharmaceuticals's investors include New Enterprise Associates (NEA), Prospect Venture Partners.
How much funding has Satori Pharmaceuticals raised?
Satori Pharmaceuticals has disclosed $15M raised across 1 round.
Where is Satori Pharmaceuticals headquartered?
Satori Pharmaceuticals is headquartered in Cambridge, US.